Cerebral chromomycosis.
Salem FA, Kannangara DW, Nachum R.
Arch Neurol. 1983 Mar;40(3):173-4. doi: 10.1001/archneur.1983.04050030067013.
Cerebral chromomycosis.
Nishitani H, Nishitani K, Numaguchi Y, Honbo S.
J Comput Assist Tomogr. 1982 Jun;6(3):624-6. doi: 10.1097/00004728-198206000-00033.
Chromomycosis.
Zaias N.
J Cutan Pathol. 1978 Aug;5(4):155-64. doi: 10.1111/j.1600-0560.1978.tb00953.x.
Cerebral chromoblastomycosis.
WATSON KC.
J Pathol Bacteriol. 1962 Jul;84:233-7. doi: 10.1002/path.1700840128.
Systemic chromomycosis.
Harada S, Ueda T, Kusunoki T.
J Dermatol. 1976 Feb;3(1):13-7. doi: 10.1111/j.1346-8138.1976.tb00964.x.
Melanized fungi in human disease.
Revankar SG, Sutton DA.
Clin Microbiol Rev. 2010 Oct;23(4):884-928. doi: 10.1128/CMR.00019-10.
Cerebral chromoblastomycosis. Case report.
Musella RA, Collins GH.
J Neurosurg. 1971 Aug;35(2):219-22. doi: 10.3171/jns.1971.35.2.0219.
Chromomycosis in Japan.
Nishimoto K.
Ann Soc Belg Med Trop. 1981 Sep;61(3):405-12.
A case of cerebral phaeohyphomycosis caused by Fonsecaea monophora, a neurotropic dematiaceous fungus, and a review of the literature.
Doymaz MZ, Seyithanoglu MF, Hakyemez İ, Gultepe BS, Cevik S, Aslan T.
Mycoses. 2015 Mar;58(3):187-92. doi: 10.1111/myc.12290. Epub 2015 Jan 15.
Spectrum of clinically significant melanized fungi in NIH hospitalized patients and their antifungal susceptibility profiles.
Vitale RG, de Hoog S, Stock F, Scudder C, Shahegh SE, Aneke CI, Tolooe A, Fennelly KP, Lionakis MS, Kwon-Chung J, Seyedmousavi A.
Med Mycol. 2025 Aug 5;63(8):myaf072. doi: 10.1093/mmy/myaf072.
